mSphereMolecular BiologyPeer-reviewed journal article
Expansion and optimization of the auxin-inducible degron 2 (AID2) system in Candida pathogens
Emily L. DanzeiseniD, Michelle V. LihoniD, Kedric L. MilhollandiD, Taylor BiasiD, Audrey F Bates, Mark C. HalliD
Abstract
The auxin-inducible degron (AID) technology is a convenient and powerful tool for protein functional characterization in a broad array of eukaryotic species. We recently demonstrated that the original AID and improved AID2 systems are very effective at rapid protein depletion in Candida albicans and described a limited set of reagents for their use in certain auxotrophic lab strains. With an eye towards broader applicability with improved flexibility, we report here a new series of template vectors suitable for employing AID2 technology in prototrophic C. albicans strains, including clinical isolates. We adapted a common recyclable antibiotic marker system for the required genome editing steps and developed a strategy for simultaneous CRISPR/Cas9-mediated tagging of both target alleles. We also developed a composite all-in-one tagging cassette that combines the degron tag and the OsTIR1F74A gene for single step strain engineering. We added a fluorescent protein tag option and designed and validated an approach for N-terminal tagging that retains natural promoter control. We also compared effectiveness of the two commonly used synthetic auxins, 5-Ph-IAA and 5-Ad-IAA and the two common OsTIR1 variants, F74A and F74G, and provide guidelines for using the new AID2 system. Finally, using the novel all-in-one cassette, we demonstrate that the AID2 system also works in Candida auris. The new reagents should enhance the convenience and accessibility of the AID2 system for the Candida research community. IMPORTANCEInvasive fungal infections, including those caused by Candida species, are a persistent global health problem, and their treatment is hindered by limited antifungal options and the emergence of drug resistance. There is an urgent need for tools and methods to accelerate discovery of novel therapeutic targets. The expanded and optimized auxin-inducible degron system described herein provides a versatile platform for characterizing protein function and dissecting pathways governing important traits like virulence, stress tolerance, and antifungal resistance. The new reagents make AID technology applicable to any strain. Ultimately, this enhanced toolkit has the potential to help identify and validate new high-value drug targets and deepen our understanding of molecular mechanisms that drive pathogenicity of Candida and other fungal pathogen species.
- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 46%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Rapid, efficient auxin-inducible protein degradation in Candida pathogens
Kedric L. Milholland, Justin B. Gregor, … Mark C. Hall·mSpherePeer-reviewed·Aug 18, 2023
- An auxin-inducible degron system for conditional mutation in the fungal meningitis pathogen Cryptococcus neoformans
Manning Y. Huang, Matthew J. Nalley, … Hiten D. Madhani·G3 Genes Genomes GeneticsPeer-reviewed·Apr 7, 2025
- An improved auxin-inducible degron system for fission yeast
Xiaoran Zhang, Lei Zhao, … Li‐Lin Du·G3 Genes Genomes GeneticsPeer-reviewed·Nov 25, 2021
- Inducible degradation of endogenous proteins by AlissAID system and development of a photoactivatable inducer.
Yoshitaka Ogawa, Kohei Nishimura, … Takumi Kamura·bioRxiv·Feb 13, 2025
- Expanding the Caenorhabditis elegans auxin-inducible degron system toolkit with internal expression and degradation controls and improved modular constructs for CRISPR/Cas9-mediated genome editing
Guinevere E. Ashley, Tam Duong, … Jordan D. Ward·GeneticsPeer-reviewed·Jan 20, 2021
- Deciphering acquired resistance mechanisms to sustained auxin-inducible protein degradation in cells and mice
Judith W. Hyle, Zhenling Liu, … Chunliang Li·bioRxiv·Sep 21, 2025